OrbiMed Advisors LLC's Form 4 filing
Passage BIO, Inc. (PASG) · filed Apr 24, 2025
- Accession no.
- 0000947871-25-000423
- Filed
- Apr 24, 2025, 5:38 PM ET
- Trade date
- Apr 22-24, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $78.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2025 | Common Stock | SSaleDisposed | −78,049 | $0.34 | −$26,536.66 | 6,807,523 | Indirect | |
| Apr 23, 2025 | Common Stock | SSaleDisposed | −89,328 | $0.34 | −$30,371.52 | 6,718,195 | Indirect | |
| Apr 24, 2025 | Common Stock | SSaleDisposed | −68,195 | $0.32 | −$21,822.4 | 6,650,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.